DIAC supports our members with regulatory information, advice and advocacy. Visit this page regularly to ensure you are aware of regulatory matters applicable to your organization. Often the bulletins and updates posted here will also be shared in DIAC's Member e-Newsletter Bite-Sized News or Regulatory Matters. Below are opportunities to participate in industry consultations. In some cases, please submit your feedback directly to the agency overseeing the consultation; in others, comments can be sent to DIAC for consolidation with MedTech If you wish to share feedback with DIAC regarding any open consultations listed below, please email us at info@diac.ca. Your comments (anonymized to protect any sensitive information) will be shared with the Regulatory & Industry Affairs Committee (RIAC) and included in DIAC or MedTech's consolidated direct response to consultations. |
Industry Consultations _____________________________________________________
December 12, 2024 - Review of Draft Guidance - Complying with the Unique Device Identification Regulations for Medical Devices The Therapeutic Goods Administration (TGA) is seeking feedback on a new guidance document being drafted for the Australian UDI system: ‘Complying with the Unique Device Identification regulations for medical devices.’ This guidance helps sponsors and manufacturers of medical devices understand their regulatory obligations under therapeutic goods legislation. Specifically, the document covers:
This document outlines the processes to get and apply a UDI, and submit and maintain UDI data in the Australian UDI Database (AusUDID). You can find the document, and provide your comments via our survey, here: Review of draft guidance - Complying with the Unique Device Identification regulations for medical devices - Therapeutic Goods Administration - Citizen Space Consultation closes on January 15, 2025 |
Updates |